发明名称 THERAPEUTIC AGENT FOR OPHTHALMIC DISEASE
摘要 <p>An agent for the prevention, treatment and/or inhibition of progression of an ophthalmic disease and an agent for the protection of an optic nerve, each of which comprises (2R)-2-propyloctanoic acid or a salt or prodrug thereof in which an amount per dose is from 0.3 ng to 5000 mg. The agents are useful for an ophthalmic disease, such as glaucoma, cataract, retinal detachment, muscae volitantes, age-related macular degeneration, diabetic retinopathy, macular edema, myopia, asthenopia, dry eye, amaurosis fugax, choked disc, papillitis optica, retrobulbar neuritis, toxic amblyopia, optic atrophy, higher visual pathway lesion, internuclear ophthalmoplegia, gaze palsy and ischemic optic neuropathy.</p>
申请公布号 EP1859795(A1) 申请公布日期 2007.11.28
申请号 EP20060729005 申请日期 2006.03.14
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 MAEGAWA, HITOSHI
分类号 A61K31/20;A61K45/00;A61P27/02;A61P27/06;A61P27/10;A61P27/12;A61P43/00 主分类号 A61K31/20
代理机构 代理人
主权项
地址